From Spatial Discovery to Clinical Deployment: Building a Multiplex Biomarker Assay for Pancreatic Cancer Research

• High-plex spatial transcriptomics as a discovery engine to reveal disease biology and prioritize biomarker candidates
• A structured path from high-plex signals to a focused low-plex assay using reproducible multiplex IHC/RNA-ISH development
• Patient stratification for pharma partners built on tumor cell state and molecular characterization

Speakers:

David Ting

Co-Director & Director - Biomarker Discovery Lab & Tumor Cartography Center, Clinical Innovation

Mass General Brigham Cancer Institute & Harvard Medical School